The analysis also uncovered a novel regulatory mechanism by which the oncogenic E2F4 transcription factor is up-regulated in breast tumors (37), linking an intron retention event in E2F4 with unfavorable prognosis in patients with breast cancer. This evidence concerns the gene E2F4 and breast carcinoma.